Posted 29 January 2021 Birmingham Brief: What happened to cancer while COVID-19 took the front seat? Professor Pam Kearns, Director of the Institute of Cancer and Genomic Sciences, writes an opinion piece on how COVID-19 has replaced cancer as 'the big C'.
Posted 12 May 2020 Major COVID-19 drugs trial begins in Birmingham A trial which will rapidly test new therapies for patients hospitalised due to COVID-19 is opening in Birmingham this week.
Posted 25 October 2019 Leading neurosurgeon highlights importance of brain tumour research Professor Colin Watts, Chair of the Birmingham Brain Cancer Program, highlights the importance of brain tumour research.
Posted 13 May 2019 £1.3 million awarded by the MRC to find new treatments for leukaemia Scientists at the University of Birmingham and Newcastle University have teamed up to develop new ways of treating different classes of Acute Myeloid Leukaemia (AML) carrying specific gene mutations.
